22 October, 2014 03:04 IST
Myiris.com - SBI Pharma Fund - SBI Mutual Fund - Scheme Details
Back
SBI Pharma Fund  NAV Rs.106.9166
Scheme Snapshot
Charts
Fund Portfolio
Peer Performance
Compare with Another Scheme
Search for Another Fund
Mutual Fund News
Historical NAVs
Dividend History
Fund Managers Interview
Holdings  As on 30-SEP-14
Top 5 holdings                As on 30-SEP-14
Sun Pharmaceutical Industries Limited 24.25
Lupin Limited 12.06
Dr Reddy`S Laboratories Limited 10.65
Aurobindo Pharma Limited 7.60
Divis Laboratories Limited 7.35
View Entire Portfolio
Search for another fund
 
OR
 
Top Performers - Sectoral-Pharma
  Scheme Name Absolute Returns
3 mths 1 yr
Click Here for Graphical Viewmore..
Asset Allocation
Equity Shares 97.79
Collateral Borrowing And Lending Obligation 2.29
Cash And Bank Deposits 0.12
Net Current Assets -0.20
As on 30-SEP-14
View Entire Asset Allocation

NAV of all options
  NAV Date
Dividend Option 88.3946 21-OCT-14
Growth Option 106.9166 21-OCT-14
Returns Calculator
For SBI Pharma Fund
If you invested
Amount Units
Amount (in Rs.)
on
Date
Calculate for Another Scheme
SIP Returns Calculator
For SBI Pharma Fund
Amount
(in Rs.)
Start Date
End Date
Calculate for Another Scheme
 Load Summary
Load Type Value Time Range(Days) Investment Range(Rs)
Entry No Load -- -- --
Exit No Load -- -- --
 Scheme Snapshot
CIO: Navneet Munot

Fund Manager: Tanmaya Desai

Address: 191, Maker Towers -E, Cuffe Parade, Mumbai - 400 005

Phone: 91 22 22180221

Fax: 91 22 22189663

website: http://www.sbimf.com
Category: Equity

Sub-Category: Sectoral-Pharma

Type: Open

Min. Investment(Rs): 2000

Total Assets(Rs./Mn): 3181.4

Registrars: Computer Age Management Services Pvt.Ltd.

Launch Date: 04-JUN-99

Scheme Objective:
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.
NAV chart of growth option





Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Tax Corner  |   NRI Centre  |  
© All rights reserved. IRIS Business Services Limited
A Disclaimer